NeuroSense Therapeutics Statistics Share Statistics NeuroSense Therapeutics has 24.67M
shares outstanding. The number of shares has increased by 6.66%
in one year.
Shares Outstanding 24.67M Shares Change (YoY) 6.66% Shares Change (QoQ) 2.83% Owned by Institutions (%) 2.08% Shares Floating 17.83M Failed to Deliver (FTD) Shares 77,999 FTD / Avg. Volume 12.09%
Short Selling Information The latest short interest is 824.89K, so 3.29% of the outstanding
shares have been sold short.
Short Interest 824.89K Short % of Shares Out 3.29% Short % of Float 3.96% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -2.19 and the forward
PE ratio is -6.15.
NeuroSense Therapeutics's PEG ratio is
0.06.
PE Ratio -2.19 Forward PE -6.15 PS Ratio 0 Forward PS 14.4 PB Ratio 8.64 P/FCF Ratio -2.2 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for NeuroSense Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.21,
with a Debt / Equity ratio of 0.03.
Current Ratio 2.21 Quick Ratio 2.21 Debt / Equity 0.03 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage -31.84
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-600.59K Employee Count 17 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -0.79% in the
last 52 weeks. The beta is 1.59, so NeuroSense Therapeutics's
price volatility has been higher than the market average.
Beta 1.59 52-Week Price Change -0.79% 50-Day Moving Average 1.27 200-Day Moving Average 1.33 Relative Strength Index (RSI) 51.16 Average Volume (20 Days) 645,223
Income Statement
Revenue n/a Gross Profit -22K Operating Income -9.9M Net Income -10.21M EBITDA -9.88M EBIT -9.9M Earnings Per Share (EPS) -0.55
Full Income Statement Balance Sheet The company has 3.38M in cash and 73K in
debt, giving a net cash position of 3.31M.
Cash & Cash Equivalents 3.38M Total Debt 73K Net Cash 3.31M Retained Earnings -36.66M Total Assets 4.58M Working Capital 2.41M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.13M
and capital expenditures -3K, giving a free cash flow of -10.14M.
Operating Cash Flow -10.13M Capital Expenditures -3K Free Cash Flow -10.14M FCF Per Share -0.54
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
